{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:12:31Z","timestamp":1787026351442,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atherosclerotic cardiovascular disease is prevalent among patients with chronic kidney disease (CKD). In this study, we initially aimed to test whether vascular calcification associated with CKD can worsen atherosclerosis. However, a paradoxical finding emerged from attempting to test this hypothesis in a mouse model of adenine-induced CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We combined adenine-induced CKD and diet-induced atherosclerosis in mice with a mutation in the low-density lipoprotein receptor gene. In the first study, mice were co-treated with 0.2% adenine in a western diet for 8 weeks to induce CKD and atherosclerosis simultaneously. In the second study, mice were pre-treated with adenine in a regular diet for 8 weeks, followed by a western diet for another 8 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Co-treatment with adenine and a western diet resulted in a reduction of plasma triglycerides and cholesterol, liver lipid contents, and atherosclerosis in co-treated mice when compared with the western-only group, despite a fully penetrant CKD phenotype developed in response to adenine. In the two-step model, renal tubulointerstitial damage and polyuria persisted after the discontinuation of adenine in the adenine-pre-treated mice. The mice, however, had similar plasma triglycerides, cholesterol, liver lipid contents, and aortic root atherosclerosis after being fed a western diet, irrespective of adenine pre-treatment. Unexpectedly, adenine pre-treated mice consumed twice the calories from the diet as those not pre-treated without showing an increase in body weight.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The adenine-induced CKD model does not recapitulate accelerated atherosclerosis, limiting its use in pre-clinical studies. The results indicate that excessive adenine intake impacts lipid metabolism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2023.1088015","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T04:57:40Z","timestamp":1675918660000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Paradoxical reduction of plasma lipids and atherosclerosis in mice with adenine-induced chronic kidney disease and hypercholesterolemia"],"prefix":"10.3389","volume":"10","author":[{"given":"Mugdha V.","family":"Padalkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra H.","family":"Tsivitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylona","family":"Gelfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Kasiyanyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Kaungumpillil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saud","family":"Nasruddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi","family":"Saji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Gilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Schram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohnish","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Savinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.kint.2016.09.049","article-title":"Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review.","volume":"91","author":"Mathew","year":"2017","journal-title":"Kidney Int."},{"key":"B2","first-page":"e563","article-title":"2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation."},{"key":"B3","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/ATVBAHA.119.312705","article-title":"Atherosclerosis in chronic kidney disease: more, less, or just different?","volume":"39","author":"Valdivielso","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jcmg.2021.10.017","article-title":"CAC for risk stratification among individuals with hypertriglyceridemia free of clinical atherosclerotic cardiovascular disease.","volume":"15","author":"Cainzos-Achirica","year":"2022","journal-title":"JACC Cardiovasc Imaging."},{"key":"B5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ki.2013.271","article-title":"Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.","volume":"85","author":"Fang","year":"2014","journal-title":"Kidney Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.kint.2016.09.024","article-title":"Vascular calcification in chronic kidney disease: different bricks in the wall?","volume":"91","author":"Vervloet","year":"2017","journal-title":"Kidney Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/toxins14040280","article-title":"Uremic toxins and cardiovascular risk in chronic kidney disease: what have we learned recently beyond the past findings?","volume":"14","author":"El Chamieh","year":"2022","journal-title":"Toxins."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2002738","DOI":"10.1002\/advs.202002738","article-title":"Mitochondrial damage-induced innate immune activation in vascular smooth muscle cells promotes chronic kidney disease-associated plaque vulnerability.","volume":"8","author":"Bi","year":"2021","journal-title":"Adv Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"102108","DOI":"10.1016\/j.redox.2021.102108","article-title":"Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine\/dimethylarginine dimethylaminotransferase 2 pathway.","volume":"46","author":"Lee","year":"2021","journal-title":"Redox Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/CIRCULATIONAHA.118.034588","article-title":"Uremic toxin indoxyl sulfate promotes proinflammatory macrophage activation via the interplay of OATP2B1 and Dll4-notch signaling.","volume":"139","author":"Nakano","year":"2019","journal-title":"Circulation."},{"key":"B11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000516013","article-title":"Hyperoxalemia leads to oxidative stress in endothelial cells and mice with chronic kidney disease.","volume":"46","author":"Sun","year":"2021","journal-title":"Kidney Blood Press Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"100120","DOI":"10.1074\/jbc.RA120.014095","article-title":"Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis.","volume":"296","author":"Mathew","year":"2021","journal-title":"J Biol Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"615816","DOI":"10.3389\/fmolb.2020.615816","article-title":"Hydrogen sulfide protects against uremic accelerated atherosclerosis via nPKC\u03b4\/Akt signal pathway.","volume":"7","author":"Lu","year":"2020","journal-title":"Front Mol Biosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3390\/antiox10101519","article-title":"Sesamol ameliorates renal injury-mediated atherosclerosis via inhibition of oxidative stress\/IKK\u03b1\/p53.","volume":"10","author":"Wang","year":"2021","journal-title":"Antioxidants."},{"key":"B15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbrc.2022.06.067","article-title":"Limited effects of systemic or renal lipoprotein lipase deficiency on renal physiology and diseases.","volume":"620","author":"Fujino","year":"2022","journal-title":"Biochem Biophys Res Commun."},{"key":"B16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000299794","article-title":"Vascular calcification in animal models of CKD: a review.","volume":"31","author":"Shobeiri","year":"2010","journal-title":"Am J Nephrol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ajpath.2020.10.012","article-title":"Lack of endothelial nitric oxide synthase accelerates ectopic calcification in uremic mice fed an adenine and high phosphorus diet.","volume":"191","author":"Oe","year":"2021","journal-title":"Am J Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"809301","DOI":"10.3389\/fcvm.2022.809301","article-title":"S2 heart sound detects aortic valve calcification independent of hemodynamic changes in mice.","volume":"9","author":"Dargam","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/path.5346","article-title":"Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model.","volume":"250","author":"Tani","year":"2020","journal-title":"J Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/CIRCRESAHA.121.319745","article-title":"Unspliced XBP1 counteracts \u03b2-catenin to inhibit vascular calcification.","volume":"130","author":"Yang","year":"2022","journal-title":"Circ Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00418-009-0557-5","article-title":"Progressive renal dysfunction and macrophage infiltration in interstitial fibrosis in an adenine-induced tubulointerstitial nephritis mouse model.","volume":"131","author":"Tamura","year":"2009","journal-title":"Histochem Cell Biol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nep.13180","article-title":"Adenine-induced chronic kidney disease in rats.","volume":"23","author":"Diwan","year":"2018","journal-title":"Nephrology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1194\/jlr.M800303-JLR200","article-title":"A new mouse mutant for the LDL receptor identified using ENU mutagenesis.","volume":"49","author":"Svenson","year":"2008","journal-title":"J Lipid Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0186426","DOI":"10.1371\/journal.pone.0186426","article-title":"Overexpression of tissue-nonspecific alkaline phosphatase (TNAP) in endothelial cells accelerates coronary artery disease in a mouse model of familial hypercholesterolemia.","volume":"12","author":"Romanelli","year":"2017","journal-title":"PLoS One."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e012486","DOI":"10.1161\/JAHA.119.012486","article-title":"Homoarginine supplementation prevents left ventricular dilatation and preserves systolic function in a model of coronary artery disease.","volume":"8","author":"Rodionov","year":"2019","journal-title":"J Am Heart Assoc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"F1169","DOI":"10.1152\/ajprenal.00676.2013","article-title":"Gender differences in adenine-induced chronic kidney disease and cardiovascular complications in rats.","volume":"307","author":"Diwan","year":"2014","journal-title":"Am J Physiol Renal Physiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1369\/jhc.2008.951582","article-title":"Oat5 and NaDC1 protein abundance in kidney and urine after renal ischemic reperfusion injury.","volume":"57","author":"Di Giusto","year":"2009","journal-title":"J Histochem Cytochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e115922","DOI":"10.1371\/journal.pone.0115922","article-title":"Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology.","volume":"9","author":"Liang","year":"2014","journal-title":"PLoS One."},{"key":"B29","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1161\/ATV.0000000000000062","article-title":"Recommendation on design, execution, and reporting of animal atherosclerosis studies: a scientific statement from the American Heart Association.","volume":"37","author":"Daugherty","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2369-14-116","article-title":"A novel model of adenine-induced tubulointerstitial nephropathy in mice.","volume":"14","author":"Jia","year":"2013","journal-title":"BMC Nephrol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1080\/09168451.2019.1650632","article-title":"The anti-inflammatory function of adenine occurs through AMPK activation and its downstream transcriptional regulation in THP-1 cells.","volume":"83","author":"Wu","year":"2019","journal-title":"Biosci Biotechnol Biochem."},{"key":"B32","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3748\/wjg.v22.i4.1664","article-title":"Mechanisms of intrahepatic triglyceride accumulation.","volume":"22","author":"Ress","year":"2016","journal-title":"World J Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1097\/01.asn.0000088024.72216.2e","article-title":"Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice.","volume":"14","author":"Bro","year":"2003","journal-title":"J Am Soc Nephrol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1681\/ASN.2004060495","article-title":"Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.","volume":"16","author":"Massy","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"B35","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41598-020-80063-0","article-title":"Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice.","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/biom12081147","article-title":"Adenine-induced nephropathy reduces atherosclerosis in ApoE knockout mice.","volume":"12","author":"Scherler","year":"2022","journal-title":"Biomolecules."},{"key":"B37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jprot.2015.03.012","article-title":"Identification of adenine modulating AMPK activation in NIH\/3T3 cells by proteomic approach.","volume":"120","author":"Young","year":"2015","journal-title":"J Proteomics."},{"key":"B38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/exd.12881","article-title":"Adenine supplement delays senescence in cultured human follicle dermal papilla cells.","volume":"25","author":"Cheng","year":"2016","journal-title":"Exp Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0142283","DOI":"10.1371\/journal.pone.0142283","article-title":"Activation of AMP-activated protein kinase by adenine alleviates TNF-alpha-induced inflammation in human umbilical vein endothelial cells.","volume":"10","author":"Cheng","year":"2015","journal-title":"PLoS One."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e21296","DOI":"10.1096\/fj.202001736RR","article-title":"Modulation of adenine phosphoribosyltransferase-mediated salvage pathway to accelerate diabetic wound healing.","volume":"35","author":"Young","year":"2021","journal-title":"FASEB J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1476-511X-10-67","article-title":"A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells.","volume":"10","author":"Lian","year":"2011","journal-title":"Lipids Health Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/bph.12932","article-title":"Effect of erythropoietin on hepatic cytochrome P450 expression and function in an adenine-fed rat model of chronic kidney disease.","volume":"172","author":"Feere","year":"2015","journal-title":"Br J Pharmacol."},{"key":"B43","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1248\/bpb.b20-00124","article-title":"Effect of chronic kidney disease on hepatic clearance of drugs in rats.","volume":"43","author":"Tokunaga","year":"2020","journal-title":"Biol Pharm Bull."},{"key":"B44","doi-asserted-by":"publisher","first-page":"263","DOI":"10.33549\/physiolres.933374","article-title":"The in vivo effects of adenine-induced chronic kidney disease on some renal and hepatic function and CYP450 metabolizing enzymes.","volume":"66","author":"Al Za\u2019abi","year":"2017","journal-title":"Physiol Res."},{"key":"B45","first-page":"1","article-title":"Animal models mimicking aminoglycoside-induced renal damage.","volume":"5","author":"Rodr\u00edguez Salgueiro","year":"2016","journal-title":"J Nephropharmacol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1088015\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T04:57:54Z","timestamp":1675918674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1088015\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":45,"alternative-id":["10.3389\/fcvm.2023.1088015"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1088015","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"article-number":"1088015"}}